Tag Archives: Vascepa

“Off-Label” Drug Marketing to be Reviewed During FDA Meeting

May 12, 2015 By: Irvin Jackson

The FDA plans to hold a public meeting this summer on off-label marketing amid increasing pressure and lawsuits from industry to allow them to promote their drugs for unapproved uses.

Philips CPAP Lawsuit Filing Deadlines May Be Approaching in Some Claims (Posted 4 days ago)

Lawyers are working to register and file Philips CPAP lawsuits, as the manufacturer may argue the June 14 anniversary of a massive recall triggered the start of the statute of limitations in certain states

More Than 60,000 Camp Lejeune Water Poisoning Claims Submitted by Injured Veterans, Family Members: Report (Posted 8 days ago)

A new report indicates the U.S. Navy is struggling to process tens of thousands of Camp Lejeune water poisoning claims due to a lack of resources.

Motion Filed to Centralize Bard Implanted Port Lawsuits in Federal Court System (Posted 8 days ago)

A group of plaintiffs have filed a motion with the U.S. JPML seeking consolidation of all Bard implanted port lawsuits before one judge for pretrial proceedings.

Tag Archives: Vascepa

“Off-Label” Drug Marketing to be Reviewed During FDA Meeting

More Top Stories

Review A Case